Daily news email for May 21, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
ElexoPharm Receives 2.1 Million EUROSTARS Grant for Program Targeting Mitochondrial ...

Vetter Boosts Quality and Logistic Processes

Definiens Expands Functionality of Its Leading Solution for Quantitative Digital Pathology with ...

Antisense Pharma Internationalizes Management Board

Mucosis Announces Positive Proof-Of-Concept Data for Mimopath® Platform In Humans

BioSpace
Johnson & Johnson Successfully Sues Chinese Distributor for Breach

SLA Pharma AG Reports Successful Phase 3 Results for Treatment of Anal Fissure

Gene Opens Unique Way to Attack Anxiety, University of Chicago Study

GenVec Inc. Appoints as President and CEO

All Baby Boomers Should be Tested for Hep C: Centers for Disease Control and Prevention (CDC)

BioSpace - Breaking News
Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) and Girindus Announce Strategic Alliance

CalAsia Pharmaceuticals Launches Structure Based Drug Discovery Ready Parkinson's Disease and CNS Related Drug Target FK506 Binding Protein-12 (FKBP12)

Cellceutix Files Amended IND With FDA for Its Novel p53

Cerecor Inc. Announces Initiation of CLIN01-002-A

600 Patients Recruited in Active Biotech AB's and Ipsen's Tasquinimod Clinical Phase III Study

Biotech News - Business Wire
New Microscope Uses Rainbow of Light to Image the Flow of Individual Blood Cells

MRI Interventions Commences Trading as a Public Company Under the Symbol MRIC

VBL Therapeutics Presents Positive Preclinical Data for VB-201 in Inflammatory Bowel Disease at Digestive Disease Week (DDW) 2012

Eureka Genomics Awarded Multi Year Contract to Assist Military Laboratory With DNA Sequencing

Cook Expands Line of Endoscopic Ultrasound Needles with Addition of Smallest Gage on the Market Designed for Histological and Cytological Samples

Biotech News - PR Newswire
El stent PROMUS Element demuestra una seguridad y efectividad excelentes en el estudio PLATINUM Small Vessel

"PLATINUM Small Vessel" studie zeigt hervorragende Langzeitergebnisse zur Sicherheit und Wirksamkeit des PROMUS Element Stents

Oncomine contributes to integrative genomic analysis of lethal castration-resistant prostate cancer

Citizen Scientists Seek Microbes at the Edge of Space

PRA Expands Operations in Europe

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
European Private Investment Fundraising Up 80 Percent

Military Veterans Support Alternative Fuels

Kythera Files to Go Public Under JOBS Act

International Doctors' Group Criticizes Gates Global Vaccines Plan

Express Scripts Settles Employee Theft Charges

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure

North American Society for the Study of Celiac Disease Calls for Industry Standardization of Gluten-Free Labeling

Research and Markets: Tension -Type Headache Global Clinical Trials Review, H1, 2012 Offers a Preliminary Coverage of Disease Clinical Trials by Their Phase, Trial Status and Prominence of the Sponsor

BrainScope® Announces Publication of Findings from Three Years of Concussion Studies in Football Players

Key Clinical Data for St. Jude Medical's Structural Heart Technologies Revealed at EuroPCR

Clinical Trials - PR Newswire
DATATRAK Selected as 2012 Crain's Leading EDGE Honoree

University Research Revealed By Southwoods Counseling May Prove Freud Right

American Society of Hypertension (ASH) 27th Annual Scientific Meeting Will Focus On New Developments In Hypertension Cause, Care And Treatment

Von Ärzten präsentierte Daten lassen vermuten, dass Ablation durch multidisziplinäre Konvergenzverfahren Patienten zu einem normalen Sinusrhythmus verhelfen kann

Study by Christiana Care Health System's Dr. Andrew Doorey identifies Unnecessary Surgeries due to Induced Vasospasm

CNN Top Stories
Flesh-eating bug victim off ventilator

Bee Gee Robin Gibb dies

Back-to-back quakes rattle Italy

Crazy protests hit Chicago

Zelizer: Blame GOP for gridlock

Contract Pharma
Girindus, Marina Biotech in Marketing Pact

PRA Expands European Ops

ICON Makes Senior Appointments

Foster Adds Manufacturing Line

bioRASI Comments on FDA Biosimilar Guidance

FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)

FDA Drug Safety Communication: Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types of malignancies

FDA News - Business Wire
Transgenomic Announces CE IVD Mark for the WAVE MCE System and SURVEYOR® Scan KRAS Kit in Europe

FDA Approves New Labeling for ISENTRESS® (raltegravir) to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability with ISENTRESS in Combination Therapy in Previously Untreated Adult Patients Infected with HIV-1

Health Outcomes Liaisons Improve Drug Reimbursement with Preemptive Payer Communication

ACRO Takes To Video To Advise FDA on Innovation

ArQule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase 3 Clinical Trial of Tivantinib in Non-Small Cell Lung Cancer

FDA Press Releases
FDA approves generic versions of blood thinner Plavix

FDA expands use for FilmArray Respiratory Panel

FDA issues alert on potential dangers of unproven treatment for multiple sclerosis

FDA proposal aims to help reduce unnecessary radiation exposure for children

FDA issues final rule on sterility testing of biological products

FDA Vaccines, Blood and Biologics - What's New
Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

Flebogamma DIF 5%

FierceBiotech
iPierian salvages new game plan after stem cell tech loses its sizzle

FDA staff backs J&J's Xarelto for heart condition

AstraZeneca pulling out all stops in R&D deal frenzy

User fee legislation promises better access, speedier reviews at FDA

UPDATED: New cloud hovers over class of 'good cholesterol' drugs

FierceBiotech IT
Memorial Day break; Twitter chat reminder

Ex-Apple CEO forecasts tech-driven change in medicine

Accelrys snaps up discovery software from Scynexis

Med device companies split on social media use

Piramal banks on pharma's data binging in $635M buyout of Decision Resources

FierceBiotech Research
2 proteins appear crucial for aggressive cancer metamorphosis

Celery extract shrinks difficult breast cancer tumor in mouse trials

Researchers find novel way to treat anxiety

Gene therapy = fountain of youth in mice

Scientist uses stem cells to rebuild bone

FiercePharma
Pfizer recalled 653,000 bottles of smelly Advil

FDA review backs Xarelto for big new use in ACS patients

How does pharma's CEO pay rank

Even some domestic firms rail at India's price control plan

Reuters: Drugmakers crafting emergency plan for Greece

FiercePharma Manufacturing
UPDATED: Hikma remediation to cost it generic sales

UPDATED: Hikma discloses FDA warning letter

Hikma discloses FDA warning letter

EU prepares tougher drug recall standards

Fewer recalls in Q1, but units pulled rocket with Novartis OTC issues

FierceVaccines
Carbohydrate, vaccine combination could push melanoma immunotherapy forward

Nasal HIV vax safe, triggers immune response

Biovest makes a move on the EU market with BiovaxID

Inovio makes steps towards a universal flu vax

Existing drugs boost new cancer vax responses

Health News - BizJournals.com
Baptist Rehab-Germantown names Hogan administrator and CEO

PneumRx buys key assets from Broncus Technologies

Humana lowering guidance because of lawsuit expenses

Dr. Mark Roh takes helm of MD Anderson Orlando

Phila.-area firm leaving town

Health News - CNBC
FDA staff sends mixed message on J&J drug Xarelto

Sigmoidoscopy an option for colon cancer screening

Missing data raise doubts on J&J drug-US FDA staff

DaVita to buy HealthCare Partners in $4.42B deal

Blasting music tied to drinking and drugs: study

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
Majority in GEN Poll Sees at Least Some Use for Bioeconomy Blueprint

Janssen Reports Positive Phase III Data for Chronic Diabetic Peripheral Neuropathy Analgesic

Osiris Wins Race to Market a Stem Cell Product with Canadian Go-Ahead

Poll Respondents Divided on Impact of FDA Legislation on Investing Environment

Aveo, Astellas Report Positive Data from Phase III Comparative Tivozanib Trial in RCC

Marketwire - Pharma and Biotech
Accelcia Business Services, Inc. and Plug and Play Tech Center Announce Strategic Partnership

BIOLASE Changes Ticker Symbol to BIOL

Cellceutix Files Amended IND With FDA for Its Novel p53 "Guardian Angel" Anti-Cancer Drug

The Boston Globe Honors Health eVillages Founder as One of the Most Innovative People in Massachusetts

Biostem U.S., Corporation Adds Jeanne Ann Lumadue, MD, PhD, MBA to Its Scientific and Medical Board of Advisors

MassBio News
MassBio Honored with NORD's Power of Partnership Award

10 reasons to attend the BIO International Convention

New Therapy Helps Patients Soar to New Heights

BIO 2012 Massachusetts Pavillion Patient Profiles

By Popular Demand: New Professional Development Courses Aim to Meet Industry Needs

Medical Pharma - PR Newswire
The Michael J. Fox Foundation Announces Second Quarter Participants in Partnering Program Between Awardees and Industry

Blut ist lebenswichtig: Tausende Hämatologen treffen sich vom 14. bis 17. Juni in Amsterdam zur 17. Jahrestagung der EHA

National Hearing Industry Alliance (NHIA) Conducts Capitol Hill Visits, Co-Hosts Hearing Care Awareness Event

Hematología: Miles de hematólogos asisten al XVII Congreso de la EHA en Ámsterdam

The Ohio State University to Place Final Beam in Topping Out Ceremony of $1.1 Billion Hospital Expansion

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
High-efficiency TALEN-based gene editing produces disease-resistant rice

Recasting natural product research

A work in progress

Drug pipeline: 1Q12

Biotech equities heat up in 1Q12

New York Times- Biotechnology
DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

White House Promotes a Bioeconomy

George Rathmann, Chief of Amgen, Dies at 84

Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

New York Times- Pharmaceuticals
A New Attack on Alzheimer’s

A Stem-Cell-Based Drug Gets Approval in Canada

WELL; F.D.A. Is Wary Of Lengthy Use Of Bone Drugs

Zytiga, a Prostate Cancer Drug, Does Well in Trial

Popular Antibiotic May Raise Risk of Sudden Death

OnBioVC
S.E.A. Medical Systems, Inc.: Series B $3M

Phosphate Therapeutics, Ltd.: Series A $13.8M

CrystalGenomics, Inc.: Series A $2.6M

Heat Biologics, Inc.: Series A $2.8M

CN Creative, Ltd: Series A $3.1M

Outsourcing-Pharma
Patheon launches CMC consultancy in face of restructuring plans

SGS adds formulation development services and expands US lab

Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst

Pharmas must give patients voice says DIA Europe director

Improve patient compliance by designing trials around real life, says expert

Pharma News - Business Wire
Dendreon Announces Data Presentation at the 2012 American Urological Association Annual Meeting

Thermo Fisher Scientific Introduces New Nano-Flow LC-MS Solution at ASMS 2012

Thermo Fisher Scientific Announces Expanded Portfolio of Applications Software for the Q Exactive Mass Spectrometer at ASMS 2012

Thermo Fisher Scientific Launches New Triple Quadrupole GC-MS System at ASMS 2012

Thermo Fisher Scientific Adds Large Molecule Functionality to its Industry-Leading LIMS for Bioanalytical Laboratories

Pharma News - PharmiWeb
PetMed Express Improves Database and Application Performance by 400 Percent

Radisphere Named a Finalist for the 2012 Red Herring Top 100 Americas Award

ICON Makes Senior Appointments in Early Phase and Epidemiology & Risk Management

Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory

Cosmetic Bootcamp Announces Multiple New Workshops at Summer Symposium

Pharma News - PR Newswire
Study Results of Novocure's NovoTTF Pivotal Phase 3 Trial Published in European Journal of Cancer

Health Robotics' i.v.STATION Robot Receives Prestigious INDUSTRIESPREIS 2012 Award for Medical Devices

PneumRx, Inc. acquiert les actifs clés de Broncus

PneumRx, Inc. adquiere los principales activos de Broncus

PneumRx, Inc. Adquire Importantes Ativos da Broncus

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

PRWeb - Biotechnology
Connections Education to Open New "Blended" High Schools for...

Genedata and Roche Extend Collaboration of Biomarker Discovery for...

Cambridge Healthtech Associates Announces Open Monoclonal Technology...

MediSend International Supports Healthcare Technology Management Week

Mind Over Matter or Just a 'state of Mind

PRWeb - Pharmaceuticals
OpenClinica at DIA China, Society for Clinical Trials Annual Meeting

Compounding Pharmacies in the US Industry Market Research Report Now...

Ruling in Actos MDL Side Effects Lawsuit Could Allow Future Plaintiffs...

New Study Warns on Increased Risk of Fracture from Nexium

A Solution to Transform Medical Research and the United States Health...

Scientific American
Climate Education Graduates to Next Level

The Stats on Statins: Should Healthy Adults Over 50 Take Them

California Considers DNA Privacy Law

Stuxnet-Like Viruses Remain a Top U.S. Security Risk

Unhurtful Thoughts: A Preoccupied Brain Produces Pain-Killing Compounds

Sports - ESPN Basketball
Ellis avoids charges but dismissed by Cincinnati

Smart: Team's success key part to VCU's move

Ellis avoids charges but dismissed by Bearcats

NCAA transfer restrictions won't be easily lifted

Old Dominion leaving CAA for Conference USA

Sports News - ESPN
Report: Air Force's top RB out amid drug probe

Report: More detailed Sandusky allegations filed

QB Olsen, brother of NFL TE, commits to Canes

Schlabach: Big 12-SEC bowl sends shockwaves

Mississippi's Brassell to transfer over eligibility

Xconomy Life Sciences
Who's on Biotech's Endangered Species List Mid-Sized Drugmakers

Sue Siegel Leaves MDV to Run $6B GE Health Unit

iPierian Zeroes In on Antibodies for Alzheimer's, Neurodegeneration

Who's on Biotech's Endangered Species List Mid-Sized Drug Developers

For Those on Watch, Hope Springs Eternal as Hair Trials Inch Along

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)